US Patent Issued to PREVIPHARMA CONSULTING on Dec. 16 for "Plasminogen for use in treating and preventing lung dysfunction" (German Inventors)

ALEXANDRIA, Va., Dec. 16 -- United States Patent no. 12,497,607, issued on Dec. 16, was assigned to PREVIPHARMA CONSULTING GMBH (Mannheim, Germany).

"Plasminogen for use in treating and preventing lung dysfunction" was invented by Stephan T. Kiessig (Wiesloch, Germany), Ricarda Welz (Mauer, Germany) and Elena Willig (Mannheim, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to plasminogen for use in a method for treating or preventing lung dysfunction associated with the formation of hyaline membranes in a patient, wherein the patient is preferably further administered with at least one plasminogen activator."

The patent was filed on April 23, 2021, under Application No....